GcMAFGlobulin component Macrophage Activating Factor (cancer treatment)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
When the Sunday People visited Lesley at her home, which she hopes to turn into a vegan B&B, she insisted her cream does not contain GcMAF, despite the similar name.
"He is also giving his son, GcMAF, which is a bloodbased product and is also completely banned.
[2] Nonstandard abbreviations: MSIA, mass spectrometric immunoassay; GcG, vitamin D binding protein (Gc-globulin); Glyc, glycated GcG; GalNAc, O-linked glycated GcG; TS, [NeuNAc.sub.1][Gal.sub.1][GalNAc.sub.1] trisaccharide; T2DM, type 2 diabetes mellitus; CVD, cardiovascular disease; GcMAF, GcG macrophage-activating factor; OEM, original equipment manufacturer; hPDQ, human proteome detection and quantification project.
Nobuto Yamamoto isolated GcMAF as a specific immunotherapy.
(8) Nagalase also blocks GcMAF, a regulatory protein that enhances the immune system through its effects on macrophages.
Ruggiero's work has focused on GcMAF (Gc protein-derived macrophage activating factor), an immune modulator that acts to stimulate immune system functioning when under attack while inhibiting immune cell activity when the danger is abated.
The key component of this super food, amongst others, is the protein GcMAF (Gc protein-derived macrophage activating factor), which could be described simplistically as carrier for the vitamin D.
GcMAF (GC protein-derived macrophage-activating factor), a protein made in the body from vitamin D3 binding protein, is attracting a great deal of attention from researchers and nonconventional practitioners as a possible anticancer and antiviral agent.
Other screening tests such as the Cologuard stool DNA test for colon cancer; the HCG test in its various forms; the PHI (phosphohexose isomerase enzyme), which goes up with anaerobic metabolism that is common in cancers; the TK1 (thymidine kinase test), which becomes elevated in some cancers; the nagalase test, which can be treated with GcMAF; the Biofocus test from Germany, which claims to do the same thing as the RGCC test; CRP and other inflammatory markers; the liquid biopsy test from Pathway Genomics, which claims to measure tumor DNA of some cancers circulating in the blood; as well as other tests that claim to diagnose cancer decades before clinical presentation.